This is a demo store. No orders will be fulfilled.
Pharmaceuticals and Biotech
-
11 Apr 2019  |  North America
Pharma Clinical Trial Digitization—Companies to Action, 2019
Collision of Healthcare with Life Sciences IT Systems will Continue to Transform the Clinical Trials Market
Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-cent...
$1,500.00 -
10 Apr 2019  |  Africa
Generic Pharmaceutical Market in Kenya and Nigeria, Forecast to 2022
Greater Regulatory Control and a Shift of Focus Away from Costly and Branded Drugs will Increase Generic Drugs’ Market Share
The African continent grapples with a huge burden of communicable diseases, particularly HIV/AIDS, tuberculosis, and malaria. With African governments facing major health financing challenges, a significant proportion of these disease areas are financed by global aid organizations that are also helping in poverty eradication in the continent. Paral...
$3,000.00 -
30 Mar 2019  |  Global
Emerging Opportunities in Synthetic Biology Platforms
Synthetic Biology as a Profound Transformative Technology
Synthetic biology is being supported by a convergence of vanguard technologies. In the era of precision medicine and smart cities, synthetic biology plays a crucial role across multiple sectors and industries. Breakthrough technologies are facilitating the successful implementation of synthetic biology approaches, and also helping in addressing the...
$4,950.00 -
20 Mar 2019  |  North America
2019 Predictions of the Global Life Sciences Industry
As Novel Technologies Find Traction, Industry Focus Will Shift Towards Successful Monetization to Deliver Value-based Care
he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...
$1,500.00 -
11 Mar 2019  |  North America
Global Cell Therapy Market—Companies to Action, 2018
A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth
The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...
$3,000.00 -
07 Mar 2019  |  North America
Mergers and Acquisitions in the Global Life Sciences Industry, 2018
M&As for Growth in Patient Engagement, Artificial Intelligence and Big Data Analytics are Driving Greater Vertical Integration
The Healthcare industry has witnessed some of the largest mega-mergers in 2018 – mergers on the provider as well as the payer ends. While this has the potential to bring a shift in power centers in the ecosystem, each stakeholder has relied heavily on inorganic growth to maintain their stronghold. This Mergers and Acquisitions in Life Sciences In...
$3,000.00 -
13 Nov 2018  |  Global
Artificial Intelligence Revolutionizing the Pharmaceutical Industry
Optimal Synergy Between Leading-edge Computational Science and Therapeutics Development
The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...
$4,950.00 -
30 Oct 2018  |  Africa
Healthcare Regulatory Environment in Kenya, Tanzania, and Ethiopia, 2018
Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement
The East African region boasts of a number of emerging leaders within Sub-Saharan Africa in terms of overall development and growth. On one hand, the region has one of the highest burdens of disease in the world, such as HIV, malaria, and tuberculosis. On the other hand, there has been a growing trend of non-communicable diseases, such as cancers a...
$1,500.00 -
24 Oct 2018  |  North America
Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025
A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market
The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...
$4,950.00 -
04 Sep 2018  |  North America
Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally ...
$3,000.00